| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |